Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer;Sumario ejecutivo de las recomendaciones SEPAR de diagnóstico y tratamiento del cáncer de pulmón de células no pequeñas

Archivos de Bronconeumologia

Volumn 52, Issue 7, 2016, Pages 378-388

  Villar Álvarez, Felipe ^a   Muguruza Trueba, Ignacio ^b   Belda Sanchis, José ^c   Molins López Rodó, Laureano ^d   Rodríguez Suárez, Pedro Miguel ^e   Sánchez de Cos Escuín, Julio ^f   Barreiro, Esther ^g   Borrego Pintado, M Henar ^h   Disdier Vicente, Carlos ^h   Flandes Aldeyturriaga, Javier ^a   Gámez García, Pablo ⁱ   Garrido López, Pilar ^j   León Atance, Pablo ^k   Izquierdo Elena, José Miguel ^l   Novoa Valentín, Nuria M ^m   Rivas de Andrés, Juan José ⁿ   Royo Crespo, Íñigo ⁿ   Salvatierra Velázquez, Ángel ^o   Seijo Maceiras, Luís M ^a   Solano Reina, Segismundo ^p   Aguiar Bujanda, David ^q   Avila Martínez, Régulo J ⁱ   de Granda Orive, Jose Ignacio ⁱ   de Higes Martinez, Eva ^r   Diaz Hellín Gude, Vicente ⁱ   Embún Flor, Raúl ⁿ   Freixinet Gilart, Jorge L ^e   García Jiménez, María Dolores ^k   Hermoso Alarza, Fátima ⁱ   Hernández Sarmiento, Samuel ^q   Honguero Martínez, Antonio Francisco ^k   Jimenez Ruiz, Carlos A ^s   López Sanz, Iker ^l   Mariscal de Alba, Andrea ⁱ   Martínez Vallina, Primitivo ⁿ   Menal Muñoz, Patricia ^t   Mezquita Pérez, Laura ^j   Olmedo García, María Eugenia ^j   Rombolá, Carlos A ^k   San Miguel Arregui, Iñigo ^u   de Valle Somiedo Gutiérrez, María ^a   Triviño Ramírez, Ana Isabel ^k   Trujillo Reyes, Joan Carles ^c   Vallejo, Carmen ^j   Vaquero Lozano, Paz ^p   Varela Simó, Gonzalo ^m   Zulueta, Javier J ^v   more..

^a HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^b Hospitales Públicos QuirónSalud Madrid   (Spain)

^c Servicio de Cirugía Torácica Hospital Universitari Mútua Terrassa   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Servicio de Cirugía Torácica Hospital Universitario de Gran Canaria Dr Negrín   (Spain)

^f HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^g INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

ⁱ HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^l HOSPITAL DONOSTIA   (Spain)

^m Universidad de Salamanca   (Spain)

ⁿ HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^o HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^p HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^q Servicio de Oncología Médica Hospital Universitario de Gran Canaria Dr Negrín   (Spain)

^r HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^s UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^t HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^u Servicio de Oncología Radioterápica Hospital Universitario de Gran Canaria Dr Negrín   (Spain)

^v UNIVERSITY CLINIC OF NAVARRA   (Spain)

more..

Author keywords

Diagnosis; Lung cancer; Recommendations; Treatment

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CARDIOVASCULAR RISK; CLINICAL FEATURE; CYTOPATHOLOGY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ENDOSCOPIC THERAPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MEDICAL EXPERT; MEDICAL SOCIETY; MINIMALLY INVASIVE PROCEDURE; NON INVASIVE PROCEDURE; NON SMALL CELL LUNG CANCER; RESPIRATORY FUNCTION; RISK FACTOR; SAMPLING; SMOKING CESSATION; SURGICAL RISK; SURGICAL TECHNIQUE; BLOOD; BRONCHOSCOPY; CHEMORADIOTHERAPY; EARLY CANCER DIAGNOSIS; LUNG RESECTION; LUNG TUMOR; ORGANIZATION AND MANAGEMENT; PALLIATIVE THERAPY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PRACTICE GUIDELINE; PULMONOLOGY; RESPIRATORY TRACT EXAMINATION; SALVAGE THERAPY; SPAIN; STANDARDS; X-RAY COMPUTED TOMOGRAPHY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CONSULTATION; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; HEALTH CARE PERSONNEL; HEALTH PROGRAM; LABORATORY TEST; LUNG SURGERY; MEDICAL SPECIALIST; MONOTHERAPY; NON INVASIVE MEASUREMENT; PREOPERATIVE EVALUATION; RISK ASSESSMENT; TOBACCO DEPENDENCE; TREATMENT RESPONSE;

TUMOR MARKER; AMFEBUTAMONE; ANTINEOPLASTIC AGENT; NICOTINE; VARENICLINE;

BIOMARKERS, TUMOR; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PALLIATIVE CARE; PNEUMONECTOMY; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PULMONARY MEDICINE; SALVAGE THERAPY; SMOKING CESSATION; SOCIETIES, MEDICAL; SPAIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85027217943     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2016.02.016     Document Type: Article

References (104)

1. 1 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [consultado 1 Jun 2014]. Disponible en: http://globocan.iarc.fr/Default.aspx.
2. 2 Lewis, S.Z., Diekemper, R., Addrizzo-Harris, D.J., Methodology for development of guidelines for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143:5 Suppl (2013), 41S–50S.
3. 3 Alberg, A.J., Ford, J.G., Samet, J.M., American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 132:3 Suppl (2007), 29S–55S.
4. 4 de Torres, J.P., Bastarrika, G., Wisnivesky, J.P., Alcaide, A.B., Campo, A., Seijo, L.M., et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 132 (2007), 1932–1938.
5. 5 Papi, A., Casoni, G., Caramori, G., Guzzinati, I., Boschetto, P., Ravenna, F., et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax. 59 (2004), 679–681.
6. 6 Cho, W.C., Kwan, C.K., Yau, S., So, P.P., Poon, P.C., Au, J.S., The role of inflammation in the pathogenesis of lung cancer. Expert Opin Ther Targets. 15 (2011), 1127–1137.
7. 7 Barreiro, E., Fermoselle, C., Mateu-Jimenez, M., Sanchez-Font, A., Pijuan, L., Gea, J., et al. Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD. Free Radic Biol Med. 65 (2013), 859–871.
8. 8 Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 Update. Clinical practice guideline. Rockville: US Department of Health and Human Services. Public Health Service; May, 2008. Traducción al español: Guía de tratamiento del tabaquismo. Jimenez Ruiz CA, Jaén CR, coordinadores de la traducción. Sociedad Española de Neumologia y Cirugia Torácica. SEPAR. Mayo del 2010.
9. 9 Cahill, K., Stevens, S., Perera, R., Lancaster, T., Pharmacological interventions for smoking cessation: An overview and network meta-analysis. Cochrane Database Syst Rev., 5, 2013, CD009329, 10.1002/14651858.CD009329.pub2.
10. 10 Leone, F.T., Evers-Casey, S., Toll, B.A., Vachani, A., Treatment of Tobacco use in lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143:Suppl (2013), 61S–77S.
11. 11 Schnoll, R.A., Martinez, E., Tatum, K.L., Weber, D.M., Kuzla, N., Glass, M., et al. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control. 21 (2010), 811–820.
12. 12 Zevallos, J.P., Mallen, M.J., Lam, C.Y., Karam-Hage, M., Blalock, J., Wetter, D.W., et al. Complications of radiotherapy in laryngopharyngeal cancer: Effects of a prospective smoking cessation program. Cancer. 115 (2009), 4636–4644.
13. 13 Marcus, P.M., Harris, A., Offord, K.P., Extended lung cancer incidence follow-up in the Mayo lung project and overdiagnosis. JNCI. 98 (2006), 748–756.
14. 14 Oken, M.M., Hocking, W.G., Kvale, P.A., Andriole, G.L., Buys, S.S., Church, T.R., et al. Screening by chest radiograph and lung cancer mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 306 (2012), 1865–1873.
15. 15 Aberle, D.R., Adams, A.M., Berg, C.D., Black, W.C., Clapp, J.D., Fagerstrom, R.M., et al., National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 365 (2011), 395–409.
16. 16 Infante, M., Cavuto, S., Lutman, F.R., Brambilla, G., Chiesa, G., Ceresoli, G., et al. A randomized study of lung cancer screening with spiral computed tomography: Three-year results from the DANTE trial. Am J Respir Crit Care Med. 180 (2009), 445–453.
17. 17 Kovalchik, S.A., Tammemagi, M., Berg, C.D., Caporaso, N.E., Riley, T.L., Korch, M., et al. Targetingof low-dose CT screening according to the risk of lung cancer death. N Engl J Med. 369 (2013), 245–254.
18. 18 De-Torres, J.P., Casanova, C., Marín, J.M., Zagaceta, J., Alcaide, A.B., Seijo, L.M., et al. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: A pilot study. Respir Med. 107 (2013), 702–707.
19. 19 Henschke, C.I., Yankelevitz, D.F., McCauley, D.I., Sone, S., Hanaoka, T., Markowitz, S., et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 355 (2006), 1763–1771.
20. 20 Pajares, M.J., Zudaire, I., Lozano, M.D., Agorreta, J., Bastarrika, G., Torre, W., et al. Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features. Cancer Epidemiol Biomarkers Prev. 15 (2006), 373–380.
21. 21 Ost, D.E., Yeung, S.C., Tanoue, L.T., Gould, M.K., Clinical and organizational factors in the initial evaluation of patients with lung cancer. Diagnosis and management of lung cancer, 3rd ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 143:Suppl (2013), e121S–e141S.
22. 22 Buccheri, G., Ferrigno, D., Lung cancer: Clinical presentation and specialist referral time. Eur Respir J. 24 (2004), 898–904.
23. 23 Tomita, M., Shimizu, T., Ayabe, T., Yonei, A., Onitsuka, T., Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer. Anticancer Res. 30 (2010), 3099–3102.
24. 24 Yan, H.J., Tan, Y., Gu, W., Neuron specific enolase and prognosis of non-small cell lung cancer: A systematic review and meta-analysis. J Buon. 19 (2014), 153–156.
25. 25 Lim, E., Baldwin, D., Beckles, M., Duffy, J., Entwisle, J., Faivre-Finn, C., et al. Guidelines on the radical management of patients with lung cancer. Thorax. 65:Suppl III (2010), 1–27.
26. 26 Gould, M.K., Donington, J., Lynch, W.R., Mazzone, P.J., Midthun, D.E., Naidich, D.P., et al. Evaluation of individuals with pulmonary nodules: When is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 143:5 Suppl (2013), e93S–120S.
27. 27 Álvarez-Martínez, C.J., Bastarrika-Alemán, G., Disdier-Vicente, C., Fernández-Villar, F., Hérnandez-Hernández, J.R., Maldonado Suárez, A., et al. Normativa SEPAR sobre el manejo del nódulo pulmonar solitario. Arch Bronconeumol. 50 (2014), 285–293.
28. 28 Seemann, M.D., Seemann, O., Luboldt, W., Bonél, H., Sittek, H., Dienemann, H., et al. Differentiation of malignant from benign solitary pulmonary lesions using chest radiography, spiral CT and HRCT. Lung Cancer. 29 (2000), 105–124.
29. 29 Jaklitsch, M., Jacobson, F.L., Austin, J.H., Field, J.K., Jett, J.R., Keshavjee, S., et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 144 (2012), 33–38.
30. 30 Silvestri, G.A., Gonzalez, A.V., Jantz, M.A., Margolis, M.L., Gould, M.K., Tanoue, L.T., et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143:5 Suppl (2013), e211S–e250S.
31. 31 De Leyn, P., Dooms, C., Kuzdzal, J., Lardinois, D., Passlick, B., Rami-Porta, R., et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 45 (2014), 787–798.
32. 32 Brunelli, A., Charloux, A., Bolliger, C.T., Rocco, G., Sculier, J.P., Varela, G., et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J. 34 (2009), 17–41.
33. 33 Brunelli, A., Kim, A.W., Berger, K.I., Addrizzo-Harris, D.J., Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143:5 Suppl (2013), e166S–e190S.
34. 34 Fleisher, L.A., Beckman, J.A., Brown, K.A., Calkins, H., Chaikof, E.L., Fleischmann, K.E., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 50 (2007), e159–e241.
35. 35 Brunelli, A., Varela, G., Salati, M., Jimenez, M.F., Pompili, C., Novoa, N., et al. Recalibration of the revised cardiac risk index in lung resection candidates. Ann Thorac Surg. 90 (2010), 199–203.
36. 36 Brunelli, A., Refai, M., Xiume, F., Salati, M., Sciarra, V., Socci, L., et al. Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection. Ann Thorac Surg. 86 (2008), 240–247.
37. 37 Rami-Porta, R., Ball, D., Crowley, J., Giroux, D.J., Jett, J., Travis, W.D., et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2 (2007), 593–602.
38. 38 Detterbeck, F., Stage classification and prediction of prognosis. Difference between accountants and speculators. J Thorac Oncol. 8 (2013), 820–822.
39. 39 Detterbeck, F.C., Lewis, S.Z., Diekemper, R., Addrizzo-Harris, D.J., Alberts, W.M., Diagnosis and management of lung cancer. 3rd ed: American College of Chest Physicians. Evidence-Based Clinical Practice Guidelines. Chest. 3 (2013), 7S–37S.
40. 40 Goldstraw, P., Crowley, J., Chansky, K., Giroux, D.J., Groome, P.A., Rami-Porta, R., et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (seventh) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2 (2007), 706–714.
41. 41 Shepherd, F.A., Crowley, J., van Houtte, P., Postmus, P.E., Carney, D., Chansky, K., et al. The International Association for the Study of Lung Cancer lung cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol. 2 (2007), 1067–1077.
42. 42 Travis, W.D., Giroux, D.J., Chansky, K., Crowley, J., Asamura, H., Brambilla, E., et al. The IASLC Lung Cancer Staging Project: Proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 3 (2008), 1213–1223.
43. 43 Travis, W.D., Brambilla, E., Burke, A.P., Marx, A., Nicholson, A.G., (eds.) World Health Organization Classification of Tumours of the Lung, Pleura, Thymus and Heart. WHO classification of tumours, 2015, International Agency for Research on Cancer, Lyon.
44. 44 Travis, W.D., Brambilla, E., Noguchi, M., Nicholson, A., Geisinger, K.R., Yatabe, Y., et al. IASLC/ATS/ERS Internacional Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 6 (2011), 244–285.
45. 45 Schwartz, A., Rezaei, Diagnostic surgical pathology in lung cancer. Diagnosis and management of lung cancer, 3rd ed: American Collage of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 14:Suppl (2013), e251S–e262S.
46. 46 Lindeman, N.I., Cagle, P.T., Beasley, M.B., Chitale, D.A., Dacic, S., Giaccone, G., et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med. 137 (2013), 828–860.
47. 47 Felip, E., Concha, A., de Castro, J., Gómez-Román, J., Garrido, P., Ramirez, J., et al. Biomarker testing in avanced non–small-cell lung cáncer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clin Transl Oncol. 17 (2015), 103–112.
48. 48 D́Urso, V., Doneddu, V., Marchesi, I., Collodoro, A., Pirina, P., Giordano, A., et al. Sputum análisis: Non-invasive early lung cancer detection. J Cell Physiol. 228 (2013), 945–951.
49. 49 Rivera, M.P., Mehta, A.C., Wahidi, M.M., Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143:5 Suppl (2013), e142S–e165S.
50. 50 Schreiber, G., McCrory, D.C., Performance characteristics of different modalities for diagnosis of suspected lung cancer: Summary of published evidence. Chest. 123:Suppl 1 (2003), 115S–128S.
51. 51 Czarnecka, K., Yasufuku, K., Interventional pulmonology: Focus on pulmonary diagnostics. Respirology. 18 (2013), 47–60.
52. 52 Terán, M.D., Brock, M.V., Staging lymph node metastases from lung cancer in the mediastinum. J Thorac Dis. 6 (2014), 230–236.
53. 53 Herth, F., Becker, H.D., Ernst, A., Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration: A randomized trial. Chest. 125 (2004), 322–325.
54. 54 Zhang, R., Ying, K., Shi, L., Zhang, L., Zhou, L., Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal lymph node staging of lung cancer: A meta-analysis. Eur J Cancer. 49 (2013), 1860–1867.
55. 55 Herth, F.J.F., Rabe, K.F., Gasparini, S., Transbronchial and transoesophageal (ultrasound-guided) needle aspirations for the analysis of mediastinal lesions. Eur Respir J. 28 (2006), 1264–1275.
56. 56 Yasufuku, K., Pierre, A., Darling, G., de Perrot, M., Waddell, T., Johnston, M., et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg. 142 (2011), 1393–1400.
57. 57 Herth, F.J.F., Eberhardt, R., Vilmann, P., Krasnik, M., Ernst, A., Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax. 61 (2006), 795–798.
58. 58 Annema, J.T., van Meerbeeck, J.P., Rintoul, R.C., Dooms, C., Deschepper, E., Dekkers, O.M., et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: A randomized trial. JAMA. 304 (2010), 2245–2252.
59. 59 Gu, P., Zhao, Y-Z., Jiang, L-Y., Zhang, W., Xin, Y., Han, B-H., Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis. Eur J Cancer. 45 (2009), 1389–1396.
60. 60 Eberhardt, R., Anantham, D., Ernst, A., Feller-Kopman, D., Herth, F., Multimodality bronchoscopic diagnosis of peripheral lung lesions: A randomized controlled trial. Am J Respir Crit Care Med. 176 (2007), 36–41.
61. 61 Seijo, L.M., de Torres, J.P., Lozano, M.D., Bastarrika, G., Alcaide, A.B., Lacunza, M.M., et al. Diagnostic yield of electromagnetic navigation bronchoscopy is highly dependent on the presence of a Bronchus sign on CT imaging: Results from a prospective study. Chest. 138 (2010), 1316–1321.
62. 62 Lerut, T., de Leyn, P., Coosemans, W., Decaluwe, H., Decker, G., Nafteux, P., et al. Cervical videomediastinoscopy. Thorac Surg Clin. 20 (2010), 195–206.
63. 63 Sánchez de Cos, J., Hernández Hernández, J., Jiménez López, M.F., Padrones Sánchez, S., Rosell Gratacós, A., Rami Porta, R., Normativa SEPAR sobre estadificación del cáncer de pulmón. Arch Bronconeumol. 47 (2011), 454–465.
64. 64 Page, A., Nakhle, G., Mercier, C., Verdant, A., Page, P., Dontigny, L., et al. Surgical treatment of bronchogenic carcinoma: The importance of staging in evaluating late survival. Can J Surg. 30 (1987), 96–99.
65. 65 Massone, P.P., Lequaglie, C., Magnani, B., Ferro, F., Cataldo, I., The real impact and usefulness of video-assisted thoracoscopic surgery in the diagnosis and therapy of clinical lymphadenopathies of the mediastinum. Ann Surg Oncol. 10 (2003), 1197–1202.
66. 66 Sebastián-Quetglás, F., Molins, L., Baldó, X., Buitrago, J., Vidal, G., Clinical value of video-assisted thoracoscopy for preoperative staging of non-small cell lung cancer. A prospective study of 105 patients. Lung Cancer. 42 (2003), 297–301.
67. 67 Tanoue, L.T., Detterbeck, F.C., New TNM classification for non-small-cell lung cancer. Expert Rev Anticancer Ther. 9 (2009), 413–423.
68. 68 Scottish Intercollegiate Guidelines Network (SIGN). Management of lung cancer. Edinburgh: SIGN; 2014. (SIGN publication no. 137). 2014 [consultado 5 Jun 2014]. Disponible en: http://www.sign.ac.uk.
69. 69 Song, W.A., Zhou, N.K., Wang, W., Chu, X.Y., Liang, C.Y., Tian, X.D., et al. Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: An updated meta-analysis of 13 randomized control trials. J Thorac Oncol. 5 (2010), 510–516.
70. 70 Albain, K.S., Rusch, V.W., Crowley, J.J., Rice, T.W., Turrisi, A.T. 3rd, Weick, J.K., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol. 13 (1995), 1880–1892.
71. 71 Fernandez, F.G., Force, S.D., Pickens, A., Kilgo, P.D., Luu, T., Miller, D.L., Impact of laterality on early and late survival after pneumonectomy. Ann Thorac Surg. 92 (2011), 244–249.
72. 72 Daly, B.D., Fernando, H.C., Ketchedjian, A., Dipetrillo, T.A., Kachnic, L.A., Morelli, D.M., et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann Thorac Surg. 82 (2006), 227–231.
73. 73 Albertucci, M., DeMeester, T.R., Rothberg, M., Hagen, J.A., Santoscoy, R., Smyrk, C., Surgery and the management of peripheral lung tumors adherent to the parietal pleura. J Thorac Cardiovasc Surg. 103 (1992), 8–12.
74. 74 Rusch, V.W., Giroux, D.J., Kraut, M.J., Crowley, J., Hazuka, M., Winton, T., et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: Long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol. 25 (2007), 313–318.
75. 75 Kozower, B.D., Larner, J.M., Detterbeck, F.C., Jones, D.R., Special treatment issues in non-small cell lung cancer. Chest. 143:Suppl (2013), e369S–e399S.
76. 76 Raz, D.J., Lanuti, M., Gaissert, H.C., Wright, C.D., Mathisen, D.J., Wain, J.C., Outcomes of patients with isolated adrenal metastasis from non-small cell lung carcinoma. Ann Thorac Surg. 92 (2011), 1788–1792.
77. 77 Kanou, T., Okami, J., Tokunaga, T., Fujiwara, A., Ishida, D., Kuno, H., et al. Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasis. Surg Today. 44 (2014), 1321–1327.
78. 78 Darling, G.E., Allen, M.S., Decker, P.A., Ballman, K., Malthaner, R.A., Inculet, R.I., et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 141 (2011), 662–670.
79. 79 Dall, K., Ford, C.H., Fisher, R., Dunning, J., Is there a survival advantage of incomplete resection of non-small-cell lung cancer that is found to be unresectable at thoracothomy?. Interact Cardiovasc Thorac Surg. 16 (2013), 529–532.
80. 80 Paul, S., Altorki, N.K., Sheng, S., Lee, P.C., Harpole, D.H., Onaitis, M.W., et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg. 139 (2010), 366–378.
81. 81 Paul, S., Isaacs, A.J., Treasure, T., Altorki, N.K., Sedrakyan, A., Long term survival with thoracoscopic versus open lobectomy: Propensity matched comparative analysis using SEER-Medicare database. BMJ., 349, 2014, g5575.
82. 82 Bao, F., Ye, P., Yang, Y., Wang, L., Zhang, C., Lv, X., et al. Segmentectomy or lobectomy for early stage lung cancer: A meta-analysis. Eur J Cardiothorac Surg. 46 (2014), 1–7.
83. 83 Zhang, Y., Sun, Y., Wang, R., Ye, T., Zhang, Y., Chen, H., Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer. J Surg Oncol. 111 (2015), 334–340.
84. 84 Shirvani, S.M., Jiang, J., Chang, J.Y., Welsh, J., Likhacheva, A., Buchholz, T.A., et al. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. JAMA Surg. 149 (2014), 1244–1253.
85. 85 Stallard, J., Loberg, A., Dunning, J., Dark, J., Is a sleeve lobectomy significantly better than a pneumonectomy. Interact Cardiovasc Thorac Surg. 11 (2010), 660–666.
86. 86 Reardon, E.S., Schrump, D.S., Extended resections of non-small cell lung cancers invading the aorta, pulmonary artery, left atrium, or esophagus: Can they be justified. Thorac Surg Clin. 24 (2014), 457–464.
87. 87 Vansteenkiste, J., Crinò, L., Dooms, C., Douillard, J.Y., Faivre-Finn, C., Lim, E., et al. 2nd ESMO Consensus Conference on Lung Cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 25 (2014), 1462–1474.
88. 88 Besse, B., Adjei, A., Baas, P., Meldgaard, P., Nicolson, M., Paz-Ares, L., et al. 2nd ESMO Consensus Conference on Lung Cancer: Non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Ann Oncol. 25 (2014), 1475–1484.
89. 89 Camps, C., Felip, E., García-Campelo, R., Trigo, J.M., Garrido, P., SEOM (Spanish Society of Medical Oncology). SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013. Clin Transl Oncol. 15 (2013), 977–984.
90. 90 Pless, M., Stupp, R., Ris, H.B., Stahel, R.A., Weder, W., Thierstein, S., et al., SAKK Lung Cancer Project Group. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: A phase 3 randomised trial. Lancet. 386 (2015), 1049–1056.
91. 91 Scagliotti, G.V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 26 (2008), 3543–3551.
92. 92 Soria, J.C., Mauguen, A., Reck, M., Sandler, A.B., Saijo, N., Johnson, D.H., et al. Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer. Ann Oncol. 24 (2013), 20–30.
93. 93 Paz-Ares, L.G., de Marinis, F., Dediu, M., Thomas, M., Pujol, J.L., Bidoli, P., et al. PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer. J Clin Oncol. 31 (2013), 2895–2902.
94. 94 Cappuzzo, F., Ciuleanu, T., Stelmakh, L., Cicenas, S., Szczésna, A., Juhász, E., et al. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: A multicentre, randomised, placebo-controlled phase 3 study. Lancet Oncol. 11 (2010), 521–529.
95. 95 Peters, S., Adjei, A.A., Gridelli, C., Reck, M., Kerr, K., Felip, E., ESMO Guidelines Working Group. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines. Ann Oncol 23:Suppl 7 (2012), vii56–vii64.
96. 96 Lee, C.K., Brown, C., Gralla, R.J., Hirsh, V., Thongprasert, S., Tsai, C.M., et al. Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: A meta-analysis. J Natl Cancer Inst. 105 (2013), 595–605.
97. 97 Shaw, A.T., Kim, D.W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.J., et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368 (2013), 2385–2394.
98. 98 Palma, D., Lagerwaard, F., Rodrigues, G., Haasbeek, C., Senan, S., Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: Stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys. 82 (2012), 1149–1156.
99. 99 Aupérin, A., le Péchoux, C., Rolland, E., Curran, W.J., Furuse, K., Fournel, P., et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 28 (2010), 2181–2190.
100. 100 Schmidt-Hansen, M., Baldwin, D.R., Hasler, E., What is the most effective follow-up model for lung cancer patients? A systematic review. J Thorac Oncol. 7 (2012), 821–824.
101. 101 Maeda, R., Yoshida, J., Hishida, T., Late recurrence of non-small cell lung cancer more than 5 years after complete resection: Incidence and clinical implications in patient follow-up. Chest. 138 (2010), 145–150.
102. 102 National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Non-small cell lung cancer. Therapy for recurrence and metastasis. Version 4. 2016. Disponible en: www.nccn.org.
103. 103 Simoff, M.J., Lally, B., Slade, M.G., Symptom management in patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest., 144, 2013, 1743.
104. 104 Du Rand, I.A., Barber, P.V., Goldring, J., British Thoracic Society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults. Thorax. 66 (2011), iii1–iii21.